Verdezyne Raises $6.3M

Carlsbad, CA-based Verdezyne, which is developing gene libraries for use in industrial biology, has raised $6.3 million of a targeted $15 million equity round, according to a recent regulatory filing. The company, which secured $9 million toward a $15 million round in February, declined to comment, so it’s unclear whether the latest funding represents additional money or a follow-on tranche of the previous round. Verdezyne has initially focused on developing renewable technologies for making adipic acid, a key feedstock chemical used to make nylon. The company’s investors include Monitor Ventures, OVP Venture Partners, the Tech Coast Angels, and the Life Sciences Angels. A representative of BP Alternative Energy Ltd. also is on its board.

Bruce V. Bigelow was the editor of Xconomy San Diego from 2008 to 2018. Read more about his life and work here. Follow @bvbigelow

Trending on Xconomy